Gaithersburg's Novavax moves into phase 3 of its of COVID-19 vaccine trial
After beginning clinical trials in May, Gaithersburg, Maryland-based Novavax has moved its COVID-19 vaccine candidate into phase three of testing. The clinical-stage biotech compan…
